Slc46a3 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA] CTD PMID:31150632 Slc46a3 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC46A3 mRNA CTD PMID:22079256 Slc46a3 Rat 1,1-dichloroethene decreases expression ISO Slc46a3 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC46A3 mRNA CTD PMID:26682919 Slc46a3 Rat 1,2-dimethylhydrazine decreases expression ISO Slc46a3 (Mus musculus) 6480464 1,2-Dimethylhydrazine results in decreased expression of SLC46A3 mRNA CTD PMID:22206623 Slc46a3 Rat 17beta-estradiol multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC46A3 mRNA CTD PMID:30165855 Slc46a3 Rat 17beta-estradiol decreases expression ISO Slc46a3 (Mus musculus) 6480464 Estradiol results in decreased expression of SLC46A3 mRNA CTD PMID:39298647 Slc46a3 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC46A3 mRNA CTD PMID:32145629 Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC46A3 mRNA; [TIPARP gene more ... CTD PMID:16214954|PMID:25975270 Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC46A3 mRNA CTD PMID:19770486|PMID:21889950|PMID:25975270|PMID:26290441|PMID:32553695 Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC46A3 mRNA CTD PMID:20702594|PMID:26377647 Slc46a3 Rat 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Slc46a3 (Mus musculus) 6480464 2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC46A3 mRNA CTD PMID:20702594 Slc46a3 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Slc46a3 Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC46A3 mRNA CTD PMID:33297965|PMID:39298647 Slc46a3 Rat 7,12-dimethyltetraphene increases expression ISO Slc46a3 (Mus musculus) 6480464 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC46A3 mRNA CTD PMID:32553695 Slc46a3 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC46A3 mRNA CTD PMID:31881176 Slc46a3 Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of SLC46A3 mRNA CTD PMID:28959563 Slc46a3 Rat aflatoxin B1 decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC46A3 mRNA CTD PMID:27153756 Slc46a3 Rat aristolochic acid A increases expression ISO SLC46A3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SLC46A3 mRNA CTD PMID:33212167 Slc46a3 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC46A3 gene CTD PMID:28931070 Slc46a3 Rat benzo[a]pyrene increases expression ISO Slc46a3 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of SLC46A3 mRNA; Benzo(a)pyrene results in increased expression of more ... CTD PMID:19770486|PMID:21569818|PMID:32417428|PMID:32553695 Slc46a3 Rat benzo[a]pyrene decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC46A3 mRNA CTD PMID:32234424 Slc46a3 Rat benzo[a]pyrene affects methylation ISO SLC46A3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC46A3 promoter CTD PMID:27901495 Slc46a3 Rat benzo[a]pyrene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113|PMID:32553695 Slc46a3 Rat benzo[b]fluoranthene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Slc46a3 Rat Benzo[k]fluoranthene increases expression ISO Slc46a3 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SLC46A3 mRNA CTD PMID:26377693 Slc46a3 Rat bis(2-chloroethyl) sulfide increases expression ISO SLC46A3 (Homo sapiens) 6480464 Mustard Gas results in increased expression of SLC46A3 mRNA CTD PMID:25102026 Slc46a3 Rat bis(2-ethylhexyl) phthalate increases expression ISO SLC46A3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of SLC46A3 mRNA CTD PMID:31163220 Slc46a3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC46A3 mRNA CTD PMID:30816183|PMID:32528016 Slc46a3 Rat bisphenol A decreases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC46A3 mRNA CTD PMID:32156529 Slc46a3 Rat bisphenol A decreases methylation ISO SLC46A3 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SLC46A3 gene CTD PMID:31601247 Slc46a3 Rat bisphenol A increases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC46A3 mRNA CTD PMID:34585602 Slc46a3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC46A3 mRNA CTD PMID:32145629 Slc46a3 Rat bisphenol F multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Slc46a3 Rat cadmium atom multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A3 more ... CTD PMID:37236586|PMID:37325564 Slc46a3 Rat cadmium dichloride multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A3 more ... CTD PMID:37236586|PMID:37325564 Slc46a3 Rat carbon nanotube decreases expression ISO Slc46a3 (Mus musculus) 6480464 Nanotubes, Carbon analog results in decreased expression of SLC46A3 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 Slc46a3 Rat cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of SLC46A3 mRNA CTD PMID:18500788 Slc46a3 Rat chlorpyrifos increases expression ISO Slc46a3 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC46A3 mRNA CTD PMID:32715474 Slc46a3 Rat chromium(6+) decreases expression ISO SLC46A3 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of SLC46A3 mRNA CTD PMID:30690063 Slc46a3 Rat chrysene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Slc46a3 Rat cisplatin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC46A3 mRNA CTD PMID:27392435 Slc46a3 Rat clofibrate decreases expression ISO Slc46a3 (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC46A3 mRNA CTD PMID:23811191 Slc46a3 Rat cyclosporin A decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC46A3 mRNA CTD PMID:20106945 Slc46a3 Rat dexamethasone multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Slc46a3 Rat dibenzofurans increases expression ISO Slc46a3 (Mus musculus) 6480464 Dibenzofurans results in increased expression of SLC46A3 mRNA CTD PMID:34254344 Slc46a3 Rat Dibutyl phosphate affects expression ISO SLC46A3 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC46A3 mRNA CTD PMID:37042841 Slc46a3 Rat dichloroacetic acid decreases expression ISO Slc46a3 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SLC46A3 mRNA CTD PMID:28962523 Slc46a3 Rat diclofenac decreases expression ISO Slc46a3 (Mus musculus) 6480464 Diclofenac results in decreased expression of SLC46A3 mRNA CTD PMID:35537566 Slc46a3 Rat dioxygen increases expression ISO SLC46A3 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC46A3 mRNA CTD PMID:26516004 Slc46a3 Rat dorsomorphin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Slc46a3 Rat doxorubicin decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC46A3 mRNA CTD PMID:29803840 Slc46a3 Rat entinostat increases expression ISO SLC46A3 (Homo sapiens) 6480464 entinostat results in increased expression of SLC46A3 mRNA CTD PMID:27188386 Slc46a3 Rat epoxiconazole affects expression ISO Slc46a3 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC46A3 mRNA CTD PMID:35436446 Slc46a3 Rat ethylparaben increases expression ISO SLC46A3 (Homo sapiens) 6480464 ethyl-p-hydroxybenzoate results in increased expression of SLC46A3 mRNA CTD PMID:37690743 Slc46a3 Rat ferric oxide decreases expression ISO Slc46a3 (Mus musculus) 6480464 ferric oxide analog results in decreased expression of SLC46A3 mRNA CTD PMID:25086211 Slc46a3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC46A3 mRNA CTD PMID:24136188 Slc46a3 Rat GSK-J4 decreases expression ISO SLC46A3 (Homo sapiens) 6480464 GSK-J4 results in decreased expression of SLC46A3 mRNA CTD PMID:29301935 Slc46a3 Rat indometacin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... CTD PMID:28628672 Slc46a3 Rat isotretinoin decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of SLC46A3 mRNA CTD PMID:20436886 Slc46a3 Rat lipopolysaccharide multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat lipopolysaccharide decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat metformin decreases expression EXP 6480464 Metformin results in decreased expression of SLC46A3 mRNA CTD PMID:31324951 Slc46a3 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of SLC46A3 mRNA CTD PMID:21515302 Slc46a3 Rat nickel sulfate increases expression ISO SLC46A3 (Homo sapiens) 6480464 nickel sulfate results in increased expression of SLC46A3 mRNA CTD PMID:22714537 Slc46a3 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat paracetamol affects expression ISO Slc46a3 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC46A3 mRNA CTD PMID:17562736 Slc46a3 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat paracetamol decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC46A3 mRNA CTD PMID:29067470 Slc46a3 Rat perfluorohexanesulfonic acid increases expression ISO Slc46a3 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of SLC46A3 mRNA CTD PMID:37995155 Slc46a3 Rat perfluorononanoic acid decreases expression ISO SLC46A3 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC46A3 mRNA CTD PMID:32588087 Slc46a3 Rat phenylmercury acetate increases expression ISO SLC46A3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SLC46A3 mRNA CTD PMID:26272509 Slc46a3 Rat phenylmercury acetate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Slc46a3 Rat pirinixic acid multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... CTD PMID:19710929 Slc46a3 Rat pirinixic acid decreases expression ISO Slc46a3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC46A3 mRNA CTD PMID:23811191 Slc46a3 Rat potassium chromate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC46A3 mRNA CTD PMID:22079256 Slc46a3 Rat potassium chromate decreases expression ISO SLC46A3 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC46A3 mRNA CTD PMID:22079256|PMID:22714537 Slc46a3 Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Slc46a3 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC46A3 mRNA CTD PMID:28903501 Slc46a3 Rat progesterone increases expression ISO SLC46A3 (Homo sapiens) 6480464 Progesterone results in increased expression of SLC46A3 mRNA CTD PMID:20864642 Slc46a3 Rat resveratrol multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC46A3 mRNA CTD PMID:23557933 Slc46a3 Rat rifampicin increases expression ISO SLC46A3 (Homo sapiens) 6480464 Rifampin results in increased expression of SLC46A3 mRNA CTD PMID:27199754 Slc46a3 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC46A3 mRNA CTD PMID:28374803 Slc46a3 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat SB 431542 multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Slc46a3 Rat silicon dioxide decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC46A3 mRNA CTD PMID:25895662 Slc46a3 Rat silicon dioxide increases expression ISO SLC46A3 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC46A3 mRNA; Silicon Dioxide results in increased more ... CTD PMID:23806026|PMID:25351596 Slc46a3 Rat sodium arsenite increases expression ISO SLC46A3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC46A3 mRNA CTD PMID:38568856 Slc46a3 Rat sodium arsenite decreases expression ISO Slc46a3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC46A3 mRNA CTD PMID:37668303|PMID:39515575 Slc46a3 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of SLC46A3 mRNA CTD PMID:19281266 Slc46a3 Rat sunitinib decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC46A3 mRNA CTD PMID:31533062 Slc46a3 Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of SLC46A3 mRNA CTD PMID:21515302 Slc46a3 Rat tetrachloroethene decreases expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of SLC46A3 mRNA CTD PMID:28973375 Slc46a3 Rat tetrachloromethane decreases expression ISO Slc46a3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA CTD PMID:27339419|PMID:31919559 Slc46a3 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA] CTD PMID:31150632 Slc46a3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA CTD PMID:31150632 Slc46a3 Rat tetraphene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of more ... CTD PMID:27858113 Slc46a3 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC46A3 mRNA CTD PMID:23411599|PMID:34492290 Slc46a3 Rat titanium dioxide decreases methylation ISO Slc46a3 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of SLC46A3 gene CTD PMID:35295148 Slc46a3 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat tremolite asbestos decreases expression ISO Slc46a3 (Mus musculus) 6480464 tremolite results in decreased expression of SLC46A3 mRNA CTD PMID:29279043 Slc46a3 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat trichostatin A increases expression ISO SLC46A3 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC46A3 mRNA CTD PMID:24935251 Slc46a3 Rat triphenyl phosphate affects expression ISO SLC46A3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC46A3 mRNA CTD PMID:37042841 Slc46a3 Rat trovafloxacin decreases expression ISO Slc46a3 (Mus musculus) 6480464 trovafloxacin results in decreased expression of SLC46A3 mRNA CTD PMID:35537566 Slc46a3 Rat valproic acid increases expression ISO Slc46a3 (Mus musculus) 6480464 Valproic Acid results in increased expression of SLC46A3 mRNA CTD PMID:21427059 Slc46a3 Rat valproic acid increases expression ISO SLC46A3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC46A3 mRNA CTD PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 Slc46a3 Rat valproic acid multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Slc46a3 Rat valproic acid affects expression ISO SLC46A3 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC46A3 mRNA CTD PMID:25979313 Slc46a3 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC46A3 mRNA CTD PMID:23034163 Slc46a3 Rat zoledronic acid increases expression ISO SLC46A3 (Homo sapiens) 6480464 zoledronic acid results in increased expression of SLC46A3 mRNA CTD PMID:24714768